Nalaganje...

OnabotulinumtoxinA in the treatment of neurogenic bladder

This review examines the evidence for use of onabotulinumtoxinA in the treatment of neurogenic lower urinary tract dysfunction. Since its first use in 1988 to treat detrusor sphincter dyssynergia, use of botulinum toxin has increased in this group of patients. We discuss the mechanism of action, pat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Gulamhusein, Aziz, Mangera, Altaf
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3437740/
https://ncbi.nlm.nih.gov/pubmed/22977301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S30180
Oznake: Označite
Brez oznak, prvi označite!